CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $247,777
- in 3 filings, $248K under 10b5-1 plans
Net −$207,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-27 | Kersten Dirk Director | Sale 10b5-1 | −65,403 | $44.28 | $2.9M | 565,561 |
| 2024-08-26 | Kersten Dirk Director | Sale 10b5-1 | −77,963 | $45.23 | $3.5M | 642,498 |
| 2024-08-26 | Kersten Dirk Director | Sale 10b5-1 | −11,534 | $45.79 | $528K | 630,964 |
| 2024-08-23 | Kersten Dirk Director | Sale 10b5-1 | −20,955 | $45.82 | $960K | 784,594 |
| 2024-08-23 | Kersten Dirk Director | Sale 10b5-1 | −64,133 | $46.37 | $3.0M | 720,461 |
| 2024-08-22 | Kersten Dirk Director | Sale 10b5-1 | −94,908 | $45.82 | $4.3M | 805,962 |
| 2024-08-22 | Kersten Dirk Director | Sale 10b5-1 | −413 | $46.97 | $19K | 805,549 |
| 2024-08-21 | Kersten Dirk Director | Sale 10b5-1 | −64,518 | $46.52 | $3.0M | 972,115 |
| 2024-08-21 | Kersten Dirk Director | Sale 10b5-1 | −71,245 | $47.01 | $3.3M | 900,870 |
| 2024-08-20 | Kersten Dirk Director | Sale 10b5-1 | −43,057 | $45.68 | $2.0M | 1,080,416 |
| 2024-08-20 | Kersten Dirk Director | Sale 10b5-1 | −35,457 | $46.94 | $1.7M | 1,044,959 |
| 2024-08-20 | Kersten Dirk Director | Sale 10b5-1 | −8,326 | $47.30 | $394K | 1,036,633 |
| 2024-08-19 | Scalzo Richard William SVP, Head of Finance & Admin. | Sale 10b5-1 | −2,442 | $45.01 | $110K | 111,332 |
| 2024-08-19 | Scalzo Richard William SVP, Head of Finance & Admin. | Sale 10b5-1 | −310 | $46.00 | $14K | 111,022 |
| 2024-08-19 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −2,400 | $45.01 | $108K | 132,411 |
| 2024-08-19 | McNeill Jonathan Chief Business Officer | Sale 10b5-1 | −305 | $46.00 | $14K | 132,106 |
| 2024-08-19 | Farwell Wildon Chief Medical Officer | Sale 10b5-1 | −2,060 | $45.01 | $93K | 143,483 |
| 2024-08-19 | Farwell Wildon Chief Medical Officer | Sale 10b5-1 | −261 | $46.00 | $12K | 143,222 |
| 2024-08-19 | HIGH SUSANNA GATTI Chief Operating Officer | Sale 10b5-1 | −2,582 | $45.01 | $116K | 146,210 |
| 2024-08-19 | HIGH SUSANNA GATTI Chief Operating Officer | Sale 10b5-1 | −328 | $46.00 | $15K | 145,882 |
Page 15 of 29 · 561 trades